Private Advisor Group LLC Sells 1,027 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Private Advisor Group LLC trimmed its holdings in Addus HomeCare Co. (NASDAQ:ADUSFree Report) by 38.1% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 1,671 shares of the company’s stock after selling 1,027 shares during the quarter. Private Advisor Group LLC’s holdings in Addus HomeCare were worth $209,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the company. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Addus HomeCare during the 3rd quarter valued at approximately $1,622,000. JPMorgan Chase & Co. raised its holdings in Addus HomeCare by 10.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company’s stock valued at $24,371,000 after buying an additional 16,997 shares during the period. Principal Financial Group Inc. grew its position in Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after acquiring an additional 75,409 shares during the last quarter. Victory Capital Management Inc. grew its position in Addus HomeCare by 6.1% in the 3rd quarter. Victory Capital Management Inc. now owns 84,960 shares of the company’s stock valued at $11,302,000 after acquiring an additional 4,913 shares during the last quarter. Finally, Quest Partners LLC grew its position in Addus HomeCare by 4,087.0% in the 3rd quarter. Quest Partners LLC now owns 11,263 shares of the company’s stock valued at $1,498,000 after acquiring an additional 10,994 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock opened at $95.29 on Friday. Addus HomeCare Co. has a one year low of $87.88 and a one year high of $136.72. The company has a market cap of $1.73 billion, a price-to-earnings ratio of 21.81, a PEG ratio of 1.41 and a beta of 0.97. The business’s 50 day moving average price is $119.86 and its 200 day moving average price is $125.12.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last issued its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $297.14 million during the quarter, compared to analyst estimates of $291.04 million. On average, analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ADUS has been the topic of a number of recent research reports. Citizens Jmp raised Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. Royal Bank of Canada reiterated an “outperform” rating and issued a $136.00 price target on shares of Addus HomeCare in a research note on Thursday, November 14th. Stephens reduced their price objective on Addus HomeCare from $153.00 to $142.00 and set an “overweight” rating for the company in a research note on Wednesday, February 26th. Oppenheimer raised their target price on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Finally, StockNews.com lowered Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. One research analyst has rated the stock with a sell rating, one has given a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, Addus HomeCare presently has a consensus rating of “Moderate Buy” and a consensus target price of $132.78.

Check Out Our Latest Stock Report on Addus HomeCare

Insider Buying and Selling

In other news, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO R Dirk Allison sold 25,000 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the sale, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.60% of the stock is currently owned by insiders.

About Addus HomeCare

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

See Also

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.